| Wanbury Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
|
|
|
|
|
|
|
|
| Particulars | Mar '2025 | Mar '2024 | Mar '2023 | Mar '2022 | Mar '2021 |
|---|---|---|---|---|---|
| Debt-Equity Ratio | 3.38 | 8.94 | 0.00 | 0.00 | 0.00 |
| Long Term Debt-Equity Ratio | 2.83 | 4.29 | 0.00 | 0.00 | 0.00 |
| Current Ratio | 0.95 | 0.58 | 0.48 | 0.42 | 0.32 |
| Fixed Assets | 2.22 | 2.37 | 2.15 | 2.31 | 1.87 |
| Inventory | 16.27 | 19.92 | 13.93 | 13.71 | 21.15 |
| Debtors | 5.91 | 7.33 | 7.58 | 10.51 | 9.21 |
| Interest Cover Ratio | 1.80 | 2.05 | 0.52 | 1.25 | 0.46 |
| PBIDTM (%) | 13.31 | 12.63 | 4.70 | 7.26 | 5.20 |
| PBITM (%) | 11.09 | 10.38 | 2.22 | 5.02 | 2.72 |
| PBDTM (%) | 7.15 | 7.58 | 0.42 | 3.23 | -0.68 |
| CPM (%) | 7.31 | 7.52 | 0.40 | 3.30 | -0.73 |
| APATM (%) | 5.09 | 5.26 | -2.08 | 1.06 | -3.21 |
| ROCE (%) | 19.97 | 31.94 | 0.00 | 17.45 | 0.00 |
| RONW (%) | 18.30 | 38.26 | 0.00 | 37.03 | 0.00 |